Related Experiment Video
Updated: Mar 15, 2026
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
The Healing Effect of Bone Marrow-Derived Stem Cells in Knee Osteoarthritis: A Case Report
Davood Mehrabani1, Fereidoon Mojtahed Jaberi2, Maryam Zakerinia3
1Stem Cell and Transgenic Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;; Department of Regenerative Medicine, University of Manitoba, Winnipeg, MB, Canada;
Abstract:
Osteoarthritis (OA) is a prevalent chronic disease impacting on quality of life and has societal and economical burden increasing with age. Yet, no confirmed pharmacological, biological or surgical therapy could prevent the progressive destruction of OA joint. Mesenchymal stem cells (MSCs) with immunosuppressive activities emerged a potential therapy. We describe a magnetic resonance images (MRI) approved 47 years old nomad female suffering from a severe right knee OA. After intra-articular injection of 36×10(6) passage 2 of bone marrow-derived stem cells (BMSCs), the patient's functional status of the knee, the number of stairs she could climb, the pain on visual analog scale (VAS) and walking distance improved after two months post-transplantation. MRI revealed an extension of the repaired tissue over subchondral bone. So as MSC transplantation is a simple technique, resulted into pain relief, minimized donor-site morbidity, provided a better quality of life, significantly improved cartilage quality with no need to hospitalization or surgery, cell transplantation can be considered as a reliable alternative treatment for chronic knee OA. Therefore these findings can be added to the literature on using BMSCs for treatment of OA.
Insights
Mesenchymal stem cell (MSC) therapy offers a promising alternative for severe knee osteoarthritis. Bone marrow-derived stem cells improved patient function, reduced pain, and enhanced cartilage quality without surgery.
Area of Science:
- Orthopedics and Regenerative Medicine
- Biotechnology and Biomedical Engineering
Background:
- Osteoarthritis (OA) is a debilitating joint disease with no cure, leading to significant disability and healthcare costs.
- Current treatments for OA focus on symptom management and do not halt disease progression.
- Mesenchymal stem cells (MSCs) show potential for OA treatment due to their regenerative and immunomodulatory properties.
Observation:
- A 47-year-old female with severe knee OA received intra-articular injection of bone marrow-derived stem cells (BMSCs).
- The patient experienced improvements in knee function, pain levels (Visual Analog Scale), and walking distance within two months.
- Magnetic resonance imaging (MRI) indicated tissue repair extending over the subchondral bone.
Findings:
- Intra-articular BMSC transplantation led to significant pain relief and functional recovery in a severe knee OA patient.
- The treatment resulted in improved cartilage quality and enhanced knee function, as evidenced by clinical assessments and MRI.
- No hospitalization or surgical intervention was required, highlighting the minimally invasive nature of the procedure.
Implications:
- Mesenchymal stem cell transplantation presents a viable, minimally invasive alternative for managing chronic knee OA.
- This approach offers improved quality of life and reduced healthcare burden compared to conventional treatments.
- Further research into BMSC therapy could revolutionize OA management and cartilage repair strategies.
More Related Videos
Related Concept Videos
01:19Mesenchymal Stem Cells
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...